Nephrotoxicity of antiinfective drugs

International Journal of Clinical Pharmacology and Therapeutics

Volumn 36, Issue 3, 1998, Pages 164-167

  Schwarz, A ^a   Perez Canto, A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antiinfective drugs; Cotrimoxazole; Immunostimulation; Interferon; Intratubular obstruction; Nephrotoxicity

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; AMPHOTERICIN B; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CIDOFOVIR; COTRIMOXAZOLE; FOSCARNET; GANCICLOVIR; INDINAVIR; INTERFERON; PENICILLIN DERIVATIVE; PENTAMIDINE; QUINOLONE DERIVATIVE; RIFAMPICIN; SULFONAMIDE;

ARTICLE; GLOMERULONEPHRITIS; HUMAN; IMMUNE DEFICIENCY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TUBULE DISORDER; NEPHROTOXICITY;

ADULT; ANTI-INFECTIVE AGENTS; AUTOIMMUNE DISEASES; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; NEPHRITIS, INTERSTITIAL; PNEUMONIA, PNEUMOCYSTIS; SULFAMETHOXAZOLE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0031952823     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Akard LP, Hoffman R 1986 Alpha interferon and immune hemolytic anemia. Ann Intern Med 105: 306
2. Averbuch SD, Austin HA, Sherwin SA, Antonovych T, Bunn PA, Longo DL 1984 Acute interstitial nephritis with the nephrotic syndrome following recombinant lymphocyte interferon A therapy for mycosis fungoides. N Engl J Med 310: 32-35
3. Barza M 1978 The nephrotoxicity of cephalosporins. J Infect Dis 137: S60-S73
4. Bean B, Aeppli D 1985 Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. J Infect Dis 151: 362-365
5. Berglund F, Killander J, Pompeius R 1975 The effect of trimethoprimsulfamethoxazole on the renal excretion of creatinine in man. J Urol 114: 802-808
6. Butler WT, Bennett JE, Ailing DW, Wertlake PT, Utz JP, Hill GJ 1964 Nephrotoxicity of Amphotericin B, early and late effects in 81 patients. Ann Intern Med 61: 175-187
7. Conlon KC et al 1990 Exacerbation of symptoms of autoimmune disease in patients receiving alpha interferon therapy. Cancer 65: 2237-2242
8. Coroneos E, Petrusevska G, Varghese F, Truong LD 1996 Focal segmental glomerulonephritis with acute renal failure associated with alpha interferon. Am J Kidney Dis 28: 888-892
9. Deray G, Martinez F, Katlama C Levaltier B, Beaufils H, Danis M, Rozenheim M, Beaumelou A, Dohin E, Gentilini M, Jacobs C 1989 Foscarnet nephrotoxicity: Mechanism, incidence and prevention. Am J Nephrol 9: 316-321
10. Dowling HF, Lepper MH 1943 Toxic reactions following therapy with sulfapyridine, sulfathiazole and sulfadiazine. J Am Med Assoc 121: 1190-1194
11. Durand JM, Retornaz F, Cretel E, Kaplanski G, Soubeyrand J 1994 Crescentic glomerulonephritis during treatment with interferon-alpha b. Am J Hematol 44: 140-141
12. Heller J, Musiolik J, Homrighausen A, Sauerbruch T, Spengler U 1996 Vorkommen und Bedeutung von Autoantikörpern im Rahmen der Interferontherapie der chronischen Hepatitis C. Dtsch Med Wochenschr 121: 1179-1183
13. Heyman SN, Clark BA, Kaiser N 1992 In-vivo and in-vitro studies on the effect of amphotericin B on endothelin release. J Antimicrob Chemother 29: 69-77
14. Herman J, Gabriel F 1987 Membranoproliferative glomerulonephritis in a patient with hairy cell leukemia treated with interferon alpha II. N Engl J Med 316: 112-113
15. Houghton DC, Hartnett M, Campbell-Boswell M, Porter G, Bennett W 1976 A light-and electron-microscopic analysis of gentamycin nephrotoxicity in rats. Am J Pathol 82: 589-612
16. Jadoul M, Piessevaux H, Ferrant A, Cosyns JP, van Ypersele de Strihou C 1995 Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon alpha 2b. Nephrol Dial Transplant 10: 111-113
17. Kalanoyides GJ 1994 Antibiotic-related nephrotoxicity. Nephrol Dial Transplant 9 (Suppl 4): 130-134
18. Kimmel PL, Abraham A, Philipps TM 1994 Membranoproliferative glomerulonephritis in a patient treated with interferon-alpha for human immunodeficiency virus infection. Am J Kidney Dis 24: 858-863
19. Koch-Weser J, Sidel VW, Dexter M, Parish C, Finer DC, Kanarek P 1971 Adverse reactions to sulfisoxazole, sulfamethoxazole, and nitrofurantoin: manifestations and specific reaction rates during 2118 courses of therapy. Arch Intern Med 128: 399-404
20. Kosek JC, Mazze RI, Cousins MJ 1974 Nephrotoxicity of gentamycin. Lab Invest 30: 48-57
21. Kovarik J, Mayer G, Pohanka E, Schwarz M, Traindl O, Graf H, Smolen J 1988 Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Transplantation 45: 402-405
22. Kramer P, Bijnen AB, Tenkate WJ, Jeekel J 1994 Recombinant leucocyte interferon A induces steroid resistant acute vascular rejection episodes in renal transplant recipients. Lancet 8348: 989-90
23. Lalezari JP, Slagg RJ, Kuppermann BD, Holland GN, Kramer F, Ives DV, Youle M, Robinson MR, Drew L, Jaffe HS 1997 Intravenous cidovir for peripheral cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 126: 257-263
24. Luft FC, Patel V, Yum MN, Kleit SA 1976 Nephrotoxicity of cephalothin-gentamycin in rats. Antimicrob Agents Chemother 9: 831-839
25. Nessi R, Bonoldi GL, Redaelli B, Di Filippo G 1976 Acute renal failure after rifampicin: a case report and review of the literature. Nephron 16: 148-159
26. Opitz A, Herrmann I, v. Herrath D, SchaeferK 1971 Akute Niereninsuffizienz nach Gentamycin-Cephalosporin-Kombinationstherapie. Med Welt 22: 434-438
27. Patel V, Luft FC, Yum MN, Patel B, Zeman W, Kleit SA 1975 Enzymuria in gentamycin-induced kidney damage. Antimicrob Agents Chemother 7: 364-369
28. Parker MG, Atkins MB, Ucci AA, Levey AS 1995 Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol 5: 1740-1744
29. Perazella MA, Mahnensmith RL 1996 Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose. Clin Nephrol 46: 187-192
30. Rönnblom LE, Alm GV et al 1991 Autoimmunity after alpha interferon therapy for malignant carcinoid tumors. Ann Intern Med 115: 178-183
31. Rostaing L, Modesto A, Baron E, Cisterne JM, Chabannier MH, Durand D 1996 Acute renal failure in kidney transplant patients treated with interpheron alpha 2b for chronic hepatitis C. Nephron 74: 512-516
32. Sacchi S, Kantarjan H, O'Brien S, Cohen PR, Pierce S, Talpaz M 1995 Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 13: 2401-2407
33. Sangster G, Kaye SB, Calman KC, Toy IL 1983 Cutaneous vasculitis associated with interferon. Eur J Can Clin Oncol 19: 1647-1649
34. Sasson JP, Dratch PL, Shortsleeve MJ 1992 Renal US findings in sulfadiazine-induced crystalluria. Radiology 185: 739-740
35. Sattler FR, Cowan R, Nielsen DM, Ruskin J 1988 Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 109: 280-287
36. Sawyer MH, Webb DE, Balow JE, Straus SE 1988 Acyclovir-induced renal failure. Am J Med 84: 1067-1071
37. Sievers TM, Kubak BM, Wong-Beringer A 1996 Safety and efficacy of intralipid emulsions of amphotericin B. J Antimicrob Chemother 38: 333-347
38. Simon DI, Brosius FC, Rothstein DM 1990 Sulfadiazine crystalluria revisited. Arch Intern Med 150: 2379-2384
39. Shouval D, Ligumsky M, Ben-Ishay D 1978 Effect of cotrimoxazole on normal creatinine clearance. Lancet I: 244-245
40. Sorkine P, Nagar H, Weinbroum A, Setton A, Israitel E, Scarlatt A, Silbiger A, Rudick V, Kluger Y, Halpern P 1996 Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically patients. Crit Care Med 24: 1311-1315
41. Stratta P, Canavese C, Dogliani M, Thea A, Degani G, Mairone L, Vercellone A 1993 Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hair cell leukemia. Renal Failure 15: 559-561
42. Takahara S, Kakimoto K, Kokado Y, Kameoka H, Ishibashi M, Kawada S, Kyo M, Nagano S, Mikami O, Okuyama A 1995 Interferon alpha therapy for chronic active hepatitis C after renal transplantation and allograft rejection. Int Urol Nephrol 27: 489-485
43. Tashima KT, Horowitz JD, Rosen S 1997 Indinavir nephropathy. N Engl J Med 336: 138-140
44. Tashiro M, Yokoyama K, Nakayama M, YamadaA, Ogura Y, Kawaguchi Y, Sakai O 1996 A case of nephrotic syndrome developing during postoperative gamma intreferone therapy for renal cell carcinoma. Nephron 73: 685-688
45. Traynor A, Kuzel T, Samuelson E, Kanwar Y 1994 Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma. Nephron 67: 94-100
46. Tucker WE 1982 Preclinical toxicology profile of acyclovir: an overview. Am J Med 73 (Suppl 1A): 27-30
47. Velazquez H, Perazella MA, Wright FS, Ellison DH 1993 Renal mechanism of trimethoprim-induced hyperkalemia. Ann Intern Med 119: 296-301
48. Wade JC, Smith C, Petty BG, Lipsky JJ, Conrad G, Ellner J, Lietman PS 1978 Cephalothin plus an aminoglykoside is more nephrotoxic than methicillin plus an aminoglykoside. Lancet II: 604-605
49. Wandl UB, Nagel-Hiemke M, May D, Kreuzfelder E, Kloke O, Kranzhoff M, Seeber S, Niederle M 1992 Lupus-like autoimmune disease by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol 65: 70-74